Pepti’s MOTS-c offer is specific enough to inspect for format and cost, while its metabolic framing remains a separate evidence question. The vial price ladder does not tell you whether care is appropriate or whether a hoped-for outcome is established. Keep the offered package, refill calendar and clinical explanation together before giving the service a place on your shortlist.
Advertised starting price
$259 / 10 mg; options through $349 / 50 mg
Billing basis
Automatic refill subscription; approximately 28-day supply, not a calendar month
A catalog that discusses energy and metabolic care is not automatically a MOTS-c catalog. CoreAge’s checked public lineup describes other products, while a current MOTS-c offer was not established. Use this review to examine that product gap and the service agreement without turning related marketing language, a commission relationship or a starting rate into evidence of equivalence.
Review scope
Provider brand; target-product availability not verified
A product image is not a route specification. The published amount and care description are useful starting information, but the package, actual renewal interval and assigned pharmacy still need confirmation. Judge the offering on the details it supplies and the answers it leaves open, without treating a familiar molecule name as proof of benefit or an individual prescription pathway.
Advertised starting price
$219 per month, as displayed; final checkout interval unverified
Promise’s product page and terms make the refill amount and cadence more visible than an unspecified monthly label. The unresolved pieces include precise route, patient-state eligibility, pharmacy assignment and independent license verification. Read current availability separately from the catalog, and compare published provider terms without turning price clarity into a clinical-quality ranking.
Advertised starting price
MOTS-c $249 first; $299 every 28 days afterward
Billing basis
Recurring subscription every 28 days; higher renewal price
State and pharmacy match
Exact product-state eligibility and dispensing pharmacy/license not independently verified
The listing gives a clear purchase unit and a separate medical-review model. It is useful for comparing service commitments. The scientific question remains separate: a native MOTS-c offer cannot inherit clinical results from an analogue or from studies measuring the body’s own peptide.
Published product price
$80 per displayed vial, before assessment and shipping.
Order charges
A $39 medical review per order; medication billed separately by the pharmacy, with $15 shipping in the reviewed product text.
Verification scope
Public product and fee information reviewed. Assigned pharmacy, individual licenses and final checkout were not independently verified.
Cienega makes the order structure relatively easy to inspect: a bottle, a separate review and no required subscription. The unresolved fields concern the exact preparation, bottle quantity and individual pharmacy assignment. The metabolism language should be assessed against the underlying research, not the order price.
Published single-product price
$99 per bottle, before the $49 medication review; not a monthly rate.
Extra order charge
One $49 medication review per order; the consultation itself is described as free.
Pharmacy check
Provider says a licensed U.S.503A pharmacy fills the prescription; individual facility and licenses not independently verified.
First, match the exact molecule and formulation. Ask whether the provider names the clinician and dispensing pharmacy, makes state coverage clear and publishes a full recurring cost. Do not turn an absent detail into a positive assumption.
Read the essential guide before treating similarly named products as equivalent, and keep the current availability distinctions alongside the provider’s claims.
Compare the commitment on equal terms
A monthly price, a 28-day refill and a three-month purchase can produce different payment schedules. Put the actual terms into the cost planner, including the introductory payment, consultation, follow-up and delivery.
What this comparison cannot establish
These are reviews of published information. They do not independently verify the quality of a dispensed product, show that a molecule works for a particular goal or replace a clinician’s assessment. Coverage is limited to the providers reviewed by this publication.
Use the question checklist to ask about missing details before providing payment or health information. Our methodology explains the comparison criteria and the distinction between editorial coverage and partner placements.